亚脂蛋白E和阿尔茨海默病病理学在非洲裔美国老年人中
Sarah K Royse1, Beth E Snitz2, Ashley V Hill3
1University of Pittsburgh Department of Epidemiology, 130 De Soto Street, Pittsburgh, PA 15261, USA; University of Pittsburgh Department of Radiology, 200 Lothrop Street, Pittsburgh, PA 15213, USA.
Neurobiology of aging
|April 6, 2024
概括
无脂蛋白E4 (APOE*4) 基因基因与白人但非非裔美国人的阿尔茨海默病粉样蛋白病理学有关. 这表明在种族化群体中对AD病理学产生不同的APOE*4影响.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 是一个遗传学.
- 老年学是一门学科.
背景情况:
- 在非裔美国人中,无脂蛋白E4 (APOE*4) 等位基因比非西班牙裔白人更为普遍.
- 在非洲裔美国人群中,APOE等位基与阿尔茨海默病 (AD) 病理,特别是β-粉样蛋白 (Aβ) 和tau之间的关联仍然不清楚.
研究的目的:
- 研究非裔美国人与非西班牙裔白人个体中APOE等位基因 (APOE*4和APOE*2) 和AD病理 (Aβ和tau) 之间的关系.
- 为了确定种族化组是否修改了APOE等位基因和AD生物标志物之间的关联.
主要方法:
- 血液样本被用来测量APOE等位基因的状态.
- 使用正子发射断层扫描 (PET) 图像来量化Aβ和tau水平.
- 回归模型分析了APOE等位基因和Aβ/tau PET之间的关联,按种族化群体分层,并测试了种族化群体相互作用.
主要成果:
- 在非西班牙裔白人参与者中,APOE*4与更高的Aβ PET负担有显著的关联 (P < 0.0001),但在非裔美国参与者中没有 (P = 0.64).
- 种族化组显著改变了APOE*4和Aβ PET之间的关联 (P < 0.0001).
- 对于与Aβ或tau的APOE等位基因关联,没有观察到其他显著的种族化群体差异.
结论:
- 在非裔美国人和非西班牙裔白人群体中,APOE*4等位基因与Aβ病理之间的关联显著不同.
- 需要进一步的研究,以确定非洲裔美国人的AD病理的替代驱动因素,以潜在的治疗向.
相关概念视频
01:26Alzheimer's Disease: Overview
468
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
468
01:22Alzheimer's Disease: Treatment
183
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
183
03:03Amyloid Fibrils
9.5K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.5K